{
    "nct_id": "NCT05778825",
    "official_title": "A Pilot Study of Oral Minoxidil for the Treatment of Persistent Hair Loss in Pediatric, Adolescent, and Young Adult Cancer Survivors",
    "inclusion_criteria": "* Patients must have been diagnosed with cancer before the age of 17.\n* They must have completed either systemic or radiation therapy (cytotoxic chemotherapy and external beam radiation therapy) for their cancer at least 1 year prior to study entry.\n* They must be between 6-18 years old at the time of enrollment.\n* They must have a clinical diagnosis of persistent or late alopecia for >6 months and that is definitely, probably, or possibly related to prior chemotherapy and/or radiation.\nHealthy volunteers allowed\nMust have minimum age of 6 Years\nMust have maximum age of 18 Years",
    "exclusion_criteria": "* Had a history of alopecia prior to systemic or radiation therapy for cancer, or has alopecia unrelated to cancer treatment.\n* Have scalp disorders that preclude the evaluation of alopecia, such as psoriasis\n* Has a known hypersensitivity to minoxidil\n* Concurrent use of other therapies for alopecia\n* Concurrent active anticancer therapies (cytotoxic, targeted, endocrine, immunologic)\n* History of chronic sclerotic cutaneous GvHD affecting the scalp\n* Active chronic cutaneous GvHD\n* History of orthostatic or symptomatic hypotension, syncope related to hypotension; systolic less than or equal than 100 (for adults) and 90 (for children) at screening.\n* Pregnancy.\n* Cardiovascular disease that in the opinion of the cardiologist makes the patient unsuitable for therapy\n* Blood pressure less than the 5th percentile or less than 90/50 mmHg for children 10 years or older",
    "miscellaneous_criteria": ""
}